Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 24, 2016The Journal of ImmunologyOpen Access

CSF-1R–Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

KBKatelyn T. ByrnePortland State UniversityNLNathan H. LeisenringDuke Medical CenterDBDavid L. BajorUniversity Hospitals of Cleveland

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Byrne et al. (2016) studied this question.

synapsesocial.com/papers/6a0cbc2c78bbbfb1e7f2601ahttps://doi.org/10.4049/jimmunol.1600146
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune Activation and a 9-Year Ongoing Complete Remission Following CD40 Antibody Therapy and Metastasectomy in a Patient with Metastatic Melanoma2014 · 44 citations
  2. 2Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses2008 · 4,072 citations
  3. 3<i>nab</i> -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer2012 · 427 citations
  4. 4CD40 Activation Induces Apoptosis in Cultured Human Hepatocytes via Induction of Cell Surface Fas Ligand Expression and Amplifies Fas-mediated Hepatocyte Death during Allograft Rejection1999 · 195 citations
  5. 5CD154–CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis†2005 · 36 citations